Suppr超能文献

表面活性剂在无定形药物中的富集:X 射线光电子能谱研究。

Surface Enrichment of Surfactants in Amorphous Drugs: An X-ray Photoelectron Spectroscopy Study.

机构信息

School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States.

Drug Product Development, Bristol Myers Squibb, 556 Morris Avenue, Summit, New Jersey 07901, United States.

出版信息

Mol Pharm. 2022 Feb 7;19(2):654-660. doi: 10.1021/acs.molpharmaceut.1c00786. Epub 2022 Jan 21.

Abstract

Surfactants are commonly incorporated into amorphous formulations to improve the wetting and dissolution of hydrophobic drugs. Using X-ray photoelectron spectroscopy, we find that a surfactant can significantly enrich at the surface of an amorphous drug, up to 100% coverage, wihout phase separation in the bulk. We compared four different surfactants (Span 80, Span 20, Tween 80, and Tween 20) in the same host acetaminophen and the same surfactant Span 80 in four different hosts (acetaminophen, lumefantrine, posaconazole, and itraconazole). For each system, the bulk concentrations of the surfactants were 0, 1, 2, 5, and 10 wt %, which cover the typical concentrations in amorphous formulations, and component miscibility in the bulk was confirmed by differential scanning calorimetry. For all systems investigated, we observed significant surface enrichment of the surfactants. For acetaminophen containing different surfactants, the strongest surface enrichment occurred for the most lipophilic Span 80 (lowest HLB), with nearly full surface coverage. For the same surfactant Span 80 doped in different drugs, the surface enrichment effect increases with the hydrophilicity of the drug (decreasing log ). These effects arise because low-surface-energy molecules (or molecular fragments) tend to enrich at a liquid/vapor interface. This study highlights the potentially large difference between the surface and bulk compositions of an amorphous formulation. Given their high mobility and low glass transition temperature, the surface enrichment of surfactants in an amorphous drug can impact its stability, wetting, and dissolution.

摘要

表面活性剂通常被纳入无定形制剂中,以提高疏水性药物的润湿性和溶解度。使用 X 射线光电子能谱,我们发现表面活性剂可以显著富集在无定形药物的表面,最高可达 100%覆盖,而在体相中没有相分离。我们比较了四种不同的表面活性剂(Span 80、Span 20、Tween 80 和 Tween 20)在相同的宿主对乙酰氨基酚和相同的表面活性剂 Span 80 在四个不同的宿主(对乙酰氨基酚、青蒿琥酯、泊沙康唑和伊曲康唑)中的情况。对于每个系统,表面活性剂的体相浓度为 0、1、2、5 和 10wt%,涵盖了无定形制剂中的典型浓度,并且通过差示扫描量热法确认了体相中的组分混溶性。对于所研究的所有系统,我们都观察到表面活性剂的显著富集。对于含有不同表面活性剂的对乙酰氨基酚,最亲脂的 Span 80(最低 HLB)表现出最强的表面富集,几乎完全覆盖了表面。对于相同的表面活性剂 Span 80 掺杂在不同的药物中,表面富集效应随着药物的亲水性(log 降低)而增加。这些效应的出现是因为低表面能的分子(或分子片段)倾向于在液体/蒸汽界面富集。本研究强调了无定形制剂表面和体相组成之间可能存在的巨大差异。鉴于其高迁移率和低玻璃化转变温度,无定形药物中表面活性剂的表面富集会影响其稳定性、润湿性和溶解度。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验